Skip to main content
Screener/Healthcare/Biotechnology

RLAY — Relay Therapeutics, Inc.

NASDAQ
$19.60-0.13 (-0.66%)
Mid CapUnder $20HealthcareHigh Beta
$3.03
$20.79
$18.68
$19.63
EPS (TTM)$-1.57
P/E Ratio-8.09
Dividend Yield—
Market Cap$3.45B
Volume1.41M
Prev Close$19.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.0M-$73.3M$-0.410.0%-2443.0%
Q4 '25$7.0M-$54.9M$-0.3291.4%-784.1%
Q3 '25$0-$74.1M$-0.43——
Q2 '25$677K-$70.4M$-0.41100.0%-10395.1%
Q1 '25$7.7M-$77.1M$-0.46100.0%-1003.6%
Q4 '24$0-$76.0M$-0.45——
Q3 '24$0-$88.1M$-0.63——
Q2 '24$0-$92.2M$-0.69——
Get Your Daily Market Recap